NBXG: Deep Discount Remains On This Tech-Heavy Fund (NYSE:NBXG)

tampatra/iStock via Getty Images Written by Nick Ackerman, co-produced by Stanford Chemist. The Neuberger Berman Next Generation Connectivity Fund (NYSE:NBXG) is a fund focused on “next-generation mobile network connectivity and technology.” Thanks to its heavy tilt toward technology companies, the fund performed quite well in 2023, and 2024 is also looking quite promising. At the…

Read More

My Best Dividend Aristocrats For April 2024

anyaberkut 2024 Review February was a solid month for the ProShares S&P 500 Dividend Aristocrat ETF (NOBL), the fund posted a gain of 2.72%. The good streak extended through March with NOBL being up another 4.19% (not factoring in the dividend payment). This has been NOBL’s best first quarter of the year since 2021. Several…

Read More

Helen Of Troy: Solid Business With A Depressed Valuation (NASDAQ:HELE)

Tony Anderson/DigitalVision via Getty Images Introduction and thesis Helen of Troy Limited (NASDAQ:HELE) is a global consumer products company headquartered in Hamilton, Bermuda. The company operates through three main segments: Housewares, Health & Home, and Beauty. Helen of Troy designs, develops, and markets a diverse portfolio of consumer products under various brand names, serving both…

Read More

Celsius Holdings Going International (NASDAQ:CELH)

Aaron Davidson Introduction Celsius Holdings (NASDAQ:CELH) is probably one of the hottest stocks on the market right now, which is unique for a company selling energy drinks. Celsius has been able to propel itself to the top through its strong brand affinity and distribution deals with large companies like PepsiCo (PEP) over the last few…

Read More

April 2024 Monthly | Seeking Alpha

MicroStockHub The macroeconomic and geopolitical developments have not changed substantially over the past month. The resilience of the US economy allows the Federal Reserve to put more emphasis on achieving price stability. While the market favors a June cut (66% vs. 80% at the end of February), it has not been fully discounted for over…

Read More

BlackBerry Q4 2023 Earnings Preview: 5 Things To Watch (NYSE:BB)

PaulMcKinnon Ahead of BlackBerry’s (NYSE:BB) third-quarter results posted in Dec. 2023, investors honed in on three things. Shareholders scrutinized the struggling firm’s earnings, assessed its new leadership under a new Chief Executive Officer, and considered the cancellation of its IoT spinoff. The stock market voted against BB stock after last quarter’s results, if readers use…

Read More

Shift4: 30% Revenue CAGR In Next 3 Years (NYSE:FOUR)

isayildiz/E+ via Getty Images Investment Thesis Shift4 (NYSE:FOUR) presents an intriguing investment opportunity supported by its strong financial performance, innovative solutions, and strategic acquisitions. With a solid track record of revenue growth, margin expansion, and efficient cost management, Shift4 is well-positioned for sustained growth of 29.6% in the next 3 years in the dynamic payment…

Read More

T. Rowe Price: Looming Interest Rate Cuts Will Turnaround Assets Under Management

RiverNorthPhotography Investment Thesis T. Rowe Price (NASDAQ:TROW) is a fundamentally solid asset manager with a long track record of outperforming relative benchmarks which has led to consistent growth in assets under management. Despite short-term challenges driven by rising interest rates which as led to net outflows over the past few years, I believe interest rate…

Read More

Meta Platforms: Buy Alert (NASDAQ:META)

Alex Wong/Getty Images News Meta Platforms (NASDAQ:META) seems to be unstoppable. After struggling to stop the exodus of users in early 2022, Meta’s CEO Mark Zuckerberg managed to execute a proper comeback in the recent year and make his company one of the most valuable businesses in the world. In recent months, Meta’s business was…

Read More

6 Stocks I’m Buying The First Week Of April

triloks Welcome back to my weekly variety show! Two of my favorite sectors of the stock market are enjoying a nice rally over the last few days. Those two sectors are Real Estate (VNQ) and Utilities (XLU). (Yes, I know — REITs and utilities. I’m really popular at cocktail parties.) Data by YCharts This mini-rally…

Read More

Why I Stopped Buying Real Estate – Part 2

Phillip Spears/DigitalVision via Getty Images Last week, I explained why I stopped buying real estate to buy real estate investment trusts, or REITs, instead. I recommend that you read the whole article, but in short, REITs (VNQ) are today a lot cheaper than private real estate. They also give you the benefits of leverage with…

Read More

Coupang Q423: Topline Growth, Intensifying Competition, Big Question On Recent Acquisition

Sundry Photography Recap In our last article on Coupang (NYSE:CPNG), we highlighted Coupang’s strong position in logistics as a key factor in driving its market share growth. Additionally, we observed robust growth in Taiwan, surpassing the growth seen in South Korea post-Rocket launch. Yet, we believe that Coupang’s stock was trading within its fair value…

Read More

Arrowhead Stock: RNAi Specialist Struggling To Show A Strong Hand (NASDAQ:ARWR)

justinkendra/iStock via Getty Images Investment Overview Back in 2019 I covered Arrowhead Pharmaceuticals (NASDAQ:ARWR), a drug developer focused on RNA-interference therapeutics in a note for Seeking Alpha. The note still provides an accurate overview of Arrowhead’s history, from acquiring RNA assets and a manufacturing facility from Swiss Pharma giant Roche (OTCQX:RHHBY), to purchasing another Swiss…

Read More

Intel Stock: Everything Rides On 18A, I’m Bullish (NASDAQ:INTC)

Sean Gallup/Getty Images News Investment Thesis In light of recent US government grants for domestic chip production, I believe Intel (NASDAQ:INTC)’s foundry business is expected to be a key factor in their future growth and currently underappreciated. Intel’s fabrication unit is starting to capitalize on the semiconductor industry’s shift towards supply chain diversification by bringing…

Read More

CRISPR: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans (CRSP)

Charday Penn/E+ via Getty Images It has been over 4 years since my last CRISPR Therapeutics (NASDAQ:CRSP) article when I was hesitant about gathering a heavy CRSP position due to the ticker’s premium valuation, volatility, and the company’s young pipeline. Yet, I was optimistic about the company’s prospects of their expansive pipeline, and partnerships. Despite…

Read More

Viatris Stock Is Still Worth Buying (NASDAQ:VTRS)

Hiroshi Watanabe/DigitalVision via Getty Images Intro & Thesis I initiated coverage on Viatris Inc (NASDAQ:VTRS) in October 2021, and then updated my bullish thesis a few months ago, stating that the stock looked dirt cheap. The VTRS stock rose significantly by 26.7% since my last update, outperforming the S&P 500 Index (SPX) (SP500): Seeking Alpha,…

Read More

PAXS CEF: PIMCO’s Newest Closed End Fund Continues To Deliver (NYSE:PAXS)

PM Images/DigitalVision via Getty Images Over the past six months, income producing assets have staged a rally, bouncing from their October bottoms. Speculation around news from the Federal Reserve points towards rate cuts sooner rather than later, sparking enthusiasm. Positive economic indicators such as easing inflation have shifted sentiment around both a hard landing and…

Read More

More On WuXi, And It Isn’t Good (WUXIF)

Golden_Brown I wrote here recently about the politically fraught state of the relations of biopharma companies with Chinese outsourcing companies, of which WuXi (OTCPK:WUXIF) is probably the most prominent. There are bills in the works in both the House (the BIOSECURE Act) and the Senate that would (among other things) restrict the ability of US…

Read More

Inflation Remained Elevated In February

JLGutierrez By William J. Luther When inflation picked back up in January 2024, many commentators described it as more noise than signal. The latest data from the Bureau of Economic Analysis (BEA) casts doubt on that view. The Personal Consumption Expenditures Price Index (PCEPI), which is the Federal Reserve’s preferred measure of inflation, grew at…

Read More

Brookfield Infrastructure Stock: Preferreds Offer 10% Yield To Probable Call (NYSE:BIP)

thitivong In our last coverage of Brookfield Infrastructure Partners L.P. (BIP), (BIPC), we highlighted some interesting opportunities in the secondary securities. In the US, there are two preferred shares listed. Brookfield Infrastructure Partners L.P. 5.125 CL A PFD13 (NYSE:BIP.PR.A) and Brookfield Infrastructure Partners L.P. 5.00% PFD A 14 (NYSE:BIP.PR.B). The two preferreds were on a…

Read More

CrowdStrike Stock: Too Much Downside Risk (NASDAQ:CRWD)

John M Lund Photography Inc CrowdStrike’s (NASDAQ:CRWD) dominance in endpoint security and adjacent markets is becoming more apparent over time. While many cybersecurity companies face an ongoing slowdown, CrowdStrike’s growth appears to be stabilizing at a reasonably high rate given the company’s size, a notion that is supported by robust hiring and reasonably aggressive long-term…

Read More

McCormick Stock: Dividend Growth And Expenses Reduction Imply Undervaluation (NYSE:MKC)

Tom Werner McCormick & Company, Incorporated (NYSE:MKC) recently delivered better than expected EPS, continues to pay dividends, and reports a 5 year dividend growth rate of 8.35%. Given recent successful pricing strategies and the global operating efficiency savings programs, I believe that we can expect operating profit margin growth and profit margin growth. In addition,…

Read More

AT&T: Still Dirt Cheap While Boasting A High Dividend Yield (Rating Upgrade) (NYSE:T)

Anne Czichos AT&T Inc. (NYSE:T) investors have done incredibly well since T bottomed out in July 2023 (remember the days when fears of lead-sheathed cables dominated?). Panic sellers bailed out in droves, unduly worried about potential multi-billion liabilities. However, dip-buyers returned with a vengeance, picking up the pieces from these sellers at T’s long-term lows….

Read More